
Mizuho Medy Co Ltd
TSE:4595

Mizuho Medy Co Ltd
Tax Provision
Mizuho Medy Co Ltd
Tax Provision Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
![]() |
Mizuho Medy Co Ltd
TSE:4595
|
Tax Provision
-ÂĄ1.4B
|
CAGR 3-Years
11%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
N/A
|
|
![]() |
Terumo Corp
TSE:4543
|
Tax Provision
-ÂĄ41.8B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-8%
|
|
![]() |
Olympus Corp
TSE:7733
|
Tax Provision
-ÂĄ12.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
9%
|
CAGR 10-Years
-17%
|
|
![]() |
Sysmex Corp
TSE:6869
|
Tax Provision
-ÂĄ27.5B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-5%
|
|
![]() |
Nihon Kohden Corp
TSE:6849
|
Tax Provision
-ÂĄ12.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-7%
|
|
![]() |
JEOL Ltd
TSE:6951
|
Tax Provision
-ÂĄ10.2B
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
-28%
|
Mizuho Medy Co Ltd
Glance View
Mizuho Medy Co., Ltd. engages in the research, development, manufacture and distribution of in-vitro diagnostic products. The company is headquartered in Tosu-Shi, Saga-Ken and currently employs 173 full-time employees. The company went IPO on 2015-12-17. The firm mainly provides in-vitro diagnostic pharmaceuticals, including immune serum test drugs, biochemical test drugs, urine and feces test drugs, microbial test drugs, blood test drugs, pathological test drugs and others, in hospital and medical practitioner fields. In addition, the Company also provides over-the-counter (OTC) drugs to pharmacies and drug stores, and sells fruit tree virus test drugs to which they apply the technology of immune serology test to agricultural test centers.

See Also
What is Mizuho Medy Co Ltd's Tax Provision?
Tax Provision
-1.4B
JPY
Based on the financial report for Dec 31, 2024, Mizuho Medy Co Ltd's Tax Provision amounts to -1.4B JPY.
What is Mizuho Medy Co Ltd's Tax Provision growth rate?
Tax Provision CAGR 5Y
-36%
Over the last year, the Tax Provision growth was 8%. The average annual Tax Provision growth rates for Mizuho Medy Co Ltd have been 11% over the past three years , -36% over the past five years .